Inhibitory effect on activated renin-angiotensin system by astragaloside IV in rats with pressure-overload induced cardiac hypertrophy

Zhongguo Zhongyao Zazhi

Volumn 34, Issue 24, 2009, Pages 3242-3246

  Shi, Hailian ^a,b   Ma, Chunlai ^c   Liu, Yan ^a   Zhou, Jiyan ^a,b   Hu, Zhibi ^a,b   Wu, Dazheng ^a,b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Shanghai Key Laboratory of Complex Prescription   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Aldosterone; Angiotensin converting enzyme; Angiotensin II; Astragaloside IV; Cardiac hypertrophy

Indexed keywords

ALDOSTERONE; ANGIOTENSIN I; ANGIOTENSIN II; ASTRAGALOSIDE IV;

ABDOMINAL AORTA; ALDOSTERONE BLOOD LEVEL; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CALCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEART; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEART VENTRICLE PRESSURE; KIDNEY; MORPHOMETRICS; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHAM PROCEDURE; UPREGULATION; WESTERN BLOTTING;

ALDOSTERONE; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPERTROPHY, LEFT VENTRICULAR; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM; SAPONINS; TRITERPENES;

EID: 77749330184     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Metcalfe B L, Huentelman M J, Parilak L D, et al. Prevention of cardiac hypertrophy by angiotensin II type-2 receptor gene transfert [J]. Hypertension, 2004,43(6):1233.
2. Chinese source
3. Chinese source
4. Chinese source
5. Chinese source
6. Chinese source
7. Chinese source
8. Schorb W, Peeler T C, Madigan N N, et al. Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts[J]. J Biol Chem, 1994,269(30):19626.
9. Buikema H, van Gilst W H, van Veldhuisen D J, et al. Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine[J]. Cardiovas Res, 1993,27(12):2118.
10. Wollert K C, Drexler H. The renin-angiotensin system and experimental heart failure[J]. Cardiovas Res, 1999,43(4):838.
11. Peach M J. Renin-angiotensin system : Biochemistry and mechanisms of action[J]. Physiol Rev, 1977,57(2):313.
12. Yayama K, Hor II M, Hiyoshi H, et al. Up-regulation of angiotensin II type 2 receptor in rat thoracic aorta by pressure-overload [J]. J Pharmacol Exp Ther, 2004,308(2):736.
13. Sadoshima J, Xu Y, Slayter H S, et al. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro[J]. Cell, 1993,75(5):977.
14. Brilla C G, Zhou C, Matsubara L S, et al. Collagen metabolism incultured adult rat cardiac fibroblasts : response to angiotensin II and aldosterone[J]. J Mol Cell Cardiol, 1994,26(7):809.
15. Falkenhahn M, Franke F, Bohle R M, et al. Cellular distribution of angiotensin -converting enzyme after myocardial infarction [J]. Hypertension, 1995,25(2):219.
16. Lijnen P J, Petrov VV, Fagard R H. Induction of cardiac fibrosis by angiotensin II[J]. Methods Find Exp Clin Pharmacol, 2000, 22(10):709.
17. De Gasparo M, Catt K J, Inagami T, et al. International union of pharmacology. XX II I. The angiotensin II receptors[J]. Pharmacol Rev, 2000,52(3):415.